Oruka Therapeutics, Inc. Increase (Decrease) in Other Current Assets and Liabilities, Net
Oruka Therapeutics, Inc. (ORKA) reported Increase (Decrease) in Other Current Assets and Liabilities, Net of $2.00 thousand for the 6-month period ending 2015-06-30, per its 10-Q filed 2015-08-11.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherCurrentAssetsAndLiabilitiesNet · last filed 2015-08-11
- Oruka Therapeutics, Inc. increase (decrease) in other current assets and liabilities, net for the quarter ending 2015-06-30 was $0.00.
- Oruka Therapeutics, Inc. increase (decrease) in other current assets and liabilities, net for the quarter ending 2015-03-31 was $2.00K.
- Oruka Therapeutics, Inc. increase (decrease) in other current assets and liabilities, net for fiscal 2014 was -$2.00K, a 113.33% decline from fiscal 2013.
- Oruka Therapeutics, Inc. increase (decrease) in other current assets and liabilities, net for fiscal 2013 was $15.00K.
| Period end | Increase (Decrease) in Other Current Assets and Liabilities, Net 3 month | Increase (Decrease) in Other Current Assets and Liabilities, Net 6 month | Increase (Decrease) in Other Current Assets and Liabilities, Net 12 month |
|---|---|---|---|
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-11 | $2.00K 10-Q · filed 2015-08-11 | |
| 2015-03-31 | $2.00K 10-Q · filed 2015-05-12 | ||
| 2014-12-31 | -$2.00K 10-K · filed 2015-03-19 | ||
| 2014-06-30 | -$1.00K 10-Q · filed 2015-08-11 | ||
| 2013-12-31 | $15.00K 10-K · filed 2015-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Veradermics, Inc (MANE) | United States | $4.839B |